|
Twist Bioscience Corporation (TWST) DCF Valoración
US | Healthcare | Medical - Diagnostics & Research | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Twist Bioscience Corporation (TWST) Bundle
Diseñada para la precisión, nuestra calculadora DCF de Twist BioScience Corporation (TWST) le permite evaluar la valoración de Twist BioScience Corporation utilizando datos financieros del mundo real, al tiempo que proporciona flexibilidad completa para modificar todos los parámetros esenciales para proyecciones mejoradas.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 90.1 | 132.3 | 203.6 | 245.1 | 313.0 | 429.4 | 589.1 | 808.3 | 1,109.0 | 1,521.5 |
| Revenue Growth, % | 0 | 46.87 | 53.83 | 20.41 | 27.69 | 37.2 | 37.2 | 37.2 | 37.2 | 37.2 |
| EBITDA | -132.1 | -143.9 | -191.6 | -174.2 | -176.7 | -362.1 | -496.8 | -681.6 | -935.1 | -1,282.9 |
| EBITDA, % | -146.6 | -108.75 | -94.1 | -71.05 | -56.46 | -84.32 | -84.32 | -84.32 | -84.32 | -84.32 |
| Depreciation | 6.7 | 12.0 | 36.6 | 29.3 | 31.4 | 48.5 | 66.5 | 91.3 | 125.3 | 171.8 |
| Depreciation, % | 7.41 | 9.06 | 18 | 11.96 | 10.04 | 11.29 | 11.29 | 11.29 | 11.29 | 11.29 |
| EBIT | -138.8 | -155.9 | -228.2 | -203.5 | -208.1 | -386.0 | -529.6 | -726.7 | -997.0 | -1,367.9 |
| EBIT, % | -154.01 | -117.81 | -112.1 | -83.01 | -66.5 | -89.9 | -89.9 | -89.9 | -89.9 | -89.9 |
| Total Cash | 290.0 | 477.9 | 505.0 | 336.4 | 276.4 | 419.4 | 575.4 | 789.4 | 1,083.0 | 1,485.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 26.4 | 28.5 | 40.3 | 44.1 | 34.9 | 85.7 | 117.6 | 161.3 | 221.3 | 303.6 |
| Account Receivables, % | 29.27 | 21.57 | 19.79 | 17.98 | 11.15 | 19.95 | 19.95 | 19.95 | 19.95 | 19.95 |
| Inventories | 12.3 | 31.8 | 39.3 | 32.1 | 24.1 | 66.8 | 91.6 | 125.7 | 172.5 | 236.6 |
| Inventories, % | 13.64 | 24.03 | 19.31 | 13.08 | 7.69 | 15.55 | 15.55 | 15.55 | 15.55 | 15.55 |
| Accounts Payable | 4.8 | 14.9 | 20.1 | 14.1 | 1.6 | 28.1 | 38.6 | 52.9 | 72.6 | 99.6 |
| Accounts Payable, % | 5.36 | 11.26 | 9.87 | 5.73 | 0.52081 | 6.55 | 6.55 | 6.55 | 6.55 | 6.55 |
| Capital Expenditure | -9.9 | -27.1 | -101.9 | -27.8 | -5.1 | -81.1 | -111.2 | -152.6 | -209.4 | -287.2 |
| Capital Expenditure, % | -10.95 | -20.45 | -50.04 | -11.33 | -1.62 | -18.88 | -18.88 | -18.88 | -18.88 | -18.88 |
| Tax Rate, % | -0.26902 | -0.26902 | -0.26902 | -0.26902 | -0.26902 | -0.26902 | -0.26902 | -0.26902 | -0.26902 | -0.26902 |
| EBITAT | -139.1 | -154.0 | -217.8 | -204.6 | -208.7 | -381.6 | -523.5 | -718.2 | -985.4 | -1,351.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -176.2 | -180.6 | -297.1 | -205.6 | -177.6 | -481.1 | -614.4 | -843.0 | -1,156.6 | -1,586.8 |
| WACC, % | 12.61 | 12.61 | 12.6 | 12.61 | 12.61 | 12.61 | 12.61 | 12.61 | 12.61 | 12.61 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -3,097.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -1,619 | |||||||||
| Terminal Value | -15,260 | |||||||||
| Present Terminal Value | -8,428 | |||||||||
| Enterprise Value | -11,526 | |||||||||
| Net Debt | -141 | |||||||||
| Equity Value | -11,385 | |||||||||
| Diluted Shares Outstanding, MM | 58 | |||||||||
| Equity Value Per Share | -196.23 |
What You Will Get
- Editable Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to generate various scenarios.
- Real-World Data: Twist Bioscience Corporation’s (TWST) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- 🔍 Real-Life TWST Financials: Pre-filled historical and projected data for Twist Bioscience Corporation (TWST).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Twist's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Twist's valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Template: Download and open the Excel file featuring Twist Bioscience Corporation’s preloaded data.
- 2. Modify Assumptions: Adjust essential inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV for (TWST).
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
- 5. Present with Confidence: Share professional valuation insights to bolster your decision-making process.
Why Choose This Calculator for Twist Bioscience (TWST)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for biotech investments.
- Flexible Inputs: Modify the highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Twist Bioscience’s intrinsic value and Net Present Value.
- Preloaded Information: Access historical and projected data for reliable analysis.
- Expert Level: Perfect for financial professionals, investors, and biotech consultants.
Who Should Use Twist Bioscience Corporation (TWST)?
- Biotech Investors: Leverage advanced tools to make informed investment choices in the biotech sector.
- Research Scientists: Access high-quality DNA synthesis services for your innovative projects.
- Pharmaceutical Consultants: Quickly tailor solutions for clients in drug development and genomics.
- Biotechnology Enthusiasts: Enhance your knowledge of synthetic biology and its applications through real-world case studies.
- Educators and Students: Utilize it as a hands-on resource in biotechnology and life sciences curricula.
What the Template Contains
- Pre-Filled DCF Model: Twist Bioscience’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Twist Bioscience’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.